References
- Cooper C , AtkinsonEJ, O‘FallonWM, MeltonLJ 3rd. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985–1989. J. Bone Miner. Res.7(2) , 221–227 (1992).
- Nevitt MC , EttingerB, BlackDM et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann. Intern. Med. 128(10) , 793–800 (1998).
- Papaioannou A , WattsNB, KendlerDL, YuenCK, AdachiJD, FerkoN. Diagnosis and management of vertebral fractures in elderly adults. Am. J. Med.113(3) , 220–228 (2002).
- Brunton S , CarmichaelB, GoldD et al. Vertebral compression fractures in primary care: recommendations from a consensus panel. J. Fam. Pract. 54(9) , 781–788 (2005).
- Tzschentke TM , ChristophT, KogelB et al. (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties. J. Pharmacol. Exp. Ther. 323(1) , 265–276 (2007).
- Daniels S , CassonE, StegmannJU et al. A randomized, double-blind, placebo-controlled Phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain. Curr. Med. Res. Opin. 25(6) , 1551–1561 (2009).
- Kleinert R , LangeC, SteupA, BlackP, GoldbergJ, DesjardinsP. Single dose analgesic efficacy of tapentadol in postsurgical dental pain: the results of a randomized, double-blind, placebo-controlled study. Anesth. Analg.107(6) , 2048–2055 (2008).
- Stegmann JU , WeberH, SteupA, OkamotoA, UpmalisD, DanielsS. The efficacy and tolerability of multiple-dose tapentadol immediate release for the relief of acute pain following orthopedic (bunionectomy) surgery. Curr. Med. Res. Opin.24(11) , 3185–3196 (2008).
- Hartrick C , Van Hove I, Stegmann JU, Oh C, Upmalis D. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, Phase III, randomized, double-blind, active- and placebo-controlled study. Clin. Ther.31(2) , 260–271 (2009).
- Hale M , UpmalisD, OkamotoA, LangeC, RauschkolbC. Tolerability of tapentadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days: a randomized, double-blind study. Curr. Med. Res. Opin.25(5) , 1095–1104 (2009).
- Daniels SE , UpmalisD, OkamotoA, LangeC, HaeusslerJ. A randomized, double-blind, Phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain. Curr. Med. Res. Opin.25(3) , 765–776 (2009).
- Folstein MF , FolsteinSE, MchughPR. ‘Mini-mental state‘. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res.12(3) , 189–198 (1975).
- Staples MP , KallmesDF, ComstockBA et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta-analysis. BMJ 343 , d3952 (2011).
- Boonen S , Van Meirhaeghe J, Bastian L et al. Balloon kyphoplasty for the treatment of acute vertebral compression fractures: 2-year results from a randomized trial. J. Bone Miner. Res.26(7) , 1627–1637 (2011).
- Kallmes DF , ComstockBA, HeagertyPJ et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N. Engl. J. Med. 361(6) , 569–579 (2009).
- Klazen CA , LohlePN, de Vries J et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open-label randomised trial. Lancet376(9746) , 1085–1092 (2010).
- Wardlaw D , CummingsSR, Van Meirhaeghe J et al. Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet373(9668) , 1016–1024 (2009).
- Chou R , BallantyneJC, FanciulloGJ, FinePG, MiaskowskiC. Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J. Pain10(2) , 147–159 (2009).
- American Geriatrics Society. Pharmacological management of persistent pain in older persons. Pain Med.10(6) , 1062–1083 (2009).
- Cauley JA , HochbergMC, LuiLY et al. Long-term risk of incident vertebral fractures. JAMA 298(23) , 2761–2767 (2007).
- Lindsay R , PackS, LiZ. Longitudinal progression of fracture prevalence through a population of postmenopausal women with osteoporosis. Osteoporos. Int.16(3) , 306–312 (2005).
- van der Klift M , de Laet CE, McCloskey EV et al. Risk factors for incident vertebral fractures in men and women: the Rotterdam Study. J. Bone Miner. Res.19(7) , 1172–1180 (2004).
▪Website
- ClinicalTrials.gov. Tapentadol IR vs oxycodone IR vs placebo in acute pain from vertebral compression fracture associated with osteoporosis. http://clinicaltrials.gov/ct2/show/NCT00771758